Large-scale implementation of insomnia treatment in routine psychiatric care: patient characteristics and insomnia-depression comorbidity.


Journal

Journal of sleep research
ISSN: 1365-2869
Titre abrégé: J Sleep Res
Pays: England
ID NLM: 9214441

Informations de publication

Date de publication:
02 2022
Historique:
revised: 28 04 2021
received: 10 12 2020
accepted: 09 07 2021
pubmed: 24 7 2021
medline: 1 2 2022
entrez: 23 7 2021
Statut: ppublish

Résumé

Treating comorbid insomnia is important for recovery from, and prevention of, depression. The objective of this study was to compare comorbidity and patient characteristics among patients having treatment for depression before and after implementation of cognitive behavioural therapy for insomnia (CBT-I) in a routine care internet treatment clinic. We hypothesized that insomnia comorbidity would be lower among patients having treatment for depression after the treatment for insomnia became available, and that depression levels would be high among patients in the insomnia treatment group compared to previous studies of insomnia. Patients were assessed face-to-face by physicians and guided through internet-delivered treatment by psychologists in a psychiatric setting. We retrieved patient data from 3 years before and 3 years after the CBT-I implementation. Measures were the Montgomery-Åsberg Depression Rating Scale-Self rated (MADRS-S) and Insomnia Severity Index (ISI). Pretreatment symptom levels were high in both the depression (MADRS-S = 23, n = 1467) and insomnia treatment (ISI = 20, n = 552) groups, indicating a true psychiatric sample. Contrary to the hypothesis, there were no significant changes in the group having treatment for depression regarding insomnia severity or comorbid insomnia diagnosis (from 66% to 68%) after CBT-I implementation. Also contrary to the hypothesis, comorbid depression levels among insomnia patients having CBT-I were similar to or slightly higher than in previous studies. It is likely that more patients with this comorbidity, who currently receive treatment for depression, would benefit from CBT-I. We suggest an emphasis on information on the benefits of CBT-I among patients and clinical staff involved in the implementation of treatments for insomnia in psychiatry, and further research into possible differences between patients actively seeking treatment for insomnia or depression.

Identifiants

pubmed: 34296806
doi: 10.1111/jsr.13448
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13448

Informations de copyright

© 2021 The Authors. Journal of Sleep Research published by John Wiley & Sons Ltd on behalf of European Sleep Research Society.

Références

Bastien, C. H., Vallières, A., & Morin, C. M. (2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2(4), 297-307. https://doi.org/10.1016/S1389-9457(00)00065-4
Blom, K., Jernelöv, S., Kraepelien, M., Bergdahl, M. O., Jungmarker, K., Ankartjärn, L., Lindefors, N., & Kaldo, V. (2015). Internet treatment addressing either insomnia or depression, for patients with both diagnoses: A randomized trial. Sleep, 38(2), 267-277. https://doi.org/10.5665/sleep.4412
Blom, K., Jernelöv, S., Rück, C., Lindefors, N., & Kaldo, V. (2017). Three-year follow-up comparing cognitive behavioral therapy for depression to cognitive behavioral therapy for insomnia, for patients with both diagnoses. Sleep, 40(8), https://doi.org/10.1093/sleep/zsx108
Blom, K., Tarkian Tillgren, H., Wiklund, T., Danlycke, E., Forssén, M., Söderström, A., Johansson, R., Hesser, H., Jernelöv, S., Lindefors, N., Andersson, G., & Kaldo, V. (2015). Internet-vs. group-delivered cognitive behavior therapy for insomnia: A randomized controlled non-inferiority trial. Behaviour Research and Therapy, 70, 47-55. https://doi.org/10.1016/j.brat.2015.05.002
Christensen, H., Batterham, P. J., Gosling, J. A., Ritterband, L. M., Griffiths, K. M., Thorndike, F. P., Glozier, N., O’Dea, B., Hickie, I. B., & Mackinnon, A. J. (2016). Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): A randomised controlled trial. The Lancet. Psychiatry, 3(4), 333-341. https://doi.org/10.1016/S2215-0366(15)00536-2
Cunningham, J. E. A., & Shapiro, C. M. (2018). Cognitive Behavioural Therapy for Insomnia (CBT-I) to treat depression: A systematic review. Journal of Psychosomatic Research, 106, 1-12. https://doi.org/10.1016/j.jpsychores.2017.12.012
Geoffroy, P. A., Hoertel, N., Etain, B., Bellivier, F., Delorme, R., Limosin, F., & Peyre, H. (2018). Insomnia and hypersomnia in major depressive episode: Prevalence, sociodemographic characteristics and psychiatric comorbidity in a population-based study. Journal of Affective Disorders, 226, 132-141. https://doi.org/10.1016/j.jad.2017.09.032
Hedman, E., Ljótsson, B., Kaldo, V., Hesser, H., El Alaoui, S., Kraepelien, M., Andersson, E., Rück, C., Svanborg, C., Andersson, G., & Lindefors, N. (2014). Effectiveness of Internet-based cognitive behaviour therapy for depression in routine psychiatric care. Journal of Affective Disorders, 155, 49-58. https://doi.org/10.1016/j.jad.2013.10.023
Kaldo, V., Jernelöv, S., Blom, K., Ljótsson, B., Brodin, M., Jörgensen, M., Kraepelien, M., Rück, C., & Lindefors, N. (2015). Guided internet cognitive behavioral therapy for insomnia compared to a control treatment-A randomized trial. Behaviour Research and Therapy, 71, 90-100. https://doi.org/10.1016/j.brat.2015.06.001
Kessler, R. C., & Bromet, E. J. (2013). The epidemiology of depression across cultures. Annual Review of Public Health, 34(1), 119-138. https://doi.org/10.1146/annurev-publhealth-031912-114409
Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
Manber, R., Buysse, D. J., Edinger, J., Krystal, A., Luther, J. F., Wisniewski, S. R., Trockel, M., Kraemer, H. C., & Thase, M. E. (2016). Efficacy of cognitive-behavioral therapy for insomnia combined with antidepressant pharmacotherapy in patients with comorbid depression and insomnia: A randomized controlled trial. The Journal of Clinical Psychiatry, 77(10), e1316-e1323. https://doi.org/10.4088/JCP.15m10244
Perlis, M. L., Giles, D. E., Buysse, D. J., Tu, X., & Kupfer, D. J. (1997). Self-reported sleep disturbance as a prodromal symptom in recurrent depression. Journal of Affective Disorders, 42(2-3), 209-212. https://doi.org/10.1016/S0165-0327(96)01411-5
Sadler, P., McLaren, S., Klein, B., Harvey, J., & Jenkins, M. (2018). Cognitive behavior therapy for older adults with insomnia and depression: A randomized controlled trial in community mental health services. Sleep, 41(8), https://doi.org/10.1093/sleep/zsy104
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., & Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59(Suppl 20), 22-33; quiz 34-57.
Svanborg, P., & Ekselius, L. (2003). Self-assessment of DSM-IV criteria for major depression in psychiatric out- and inpatients *. Nordic Journal of Psychiatry, 57(4), 291-296. https://doi.org/10.1080/08039480307281

Auteurs

Martin Kraepelien (M)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm Health Care Services, Stockholm County Council, M58, Huddinge Hospital, Stockholm, Sweden.

Erik Forsell (E)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm Health Care Services, Stockholm County Council, M58, Huddinge Hospital, Stockholm, Sweden.

Kerstin Blom (K)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm Health Care Services, Stockholm County Council, M58, Huddinge Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH